A carregar...
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
One of the last remaining clinical hurdles in the treatment of people with hemophilia is the development of inhibitors. Alloantibodies or autoantibodies directed at coagulation factors render the infusion of coagulation factor concentrates ineffective, and alternative means must be used to achieve h...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2915537/ https://ncbi.nlm.nih.gov/pubmed/20689699 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|